Clipos™ Eganelisib (IPI-549) Encapsulated Liposomes
Specifications
Description
|
PEGylated liposomes containing PI3Kγ inhibitor Eganelisib (IPI-549). Eganelisib (IPI-549) is a potent and selective PI3Kγ inhibitor (IC50 16 nM) which is reported to exhibit more than 100-fold selectivity over other lipid and protein kinases and potentiate immunotherapy with immune checkpoint inhibitors in mice. IPI-549 is insoluble in aqueous media. This product is a pre-formulated liposomal version of IPI-549 which is supplied ready to use in vitro or in vivo. The liposomes are PEGylated for optimal in vivo performance. For preclinical research use only. |
Lipid composition
|
PEGylated Liposomes |
Liposome Size
|
70-120 nm |
Lipid Molar Concentration
|
60 mM |
Encapsulated Drug
|
Eganelisib |
Drug concentration
|
2.0 mg/mL |
Inside Buffer
|
292 mM sucrose, 0.5% DPBS (1X) |
Outside Buffer
|
292 mM sucrose, 0.5% DPBS (1X) |
Storage
|
2 °C to 8 °C (do not freeze), protect from light |
Shelf-life
|
At least 1 month |
CAS No.
|
1693758-51-8 |
Related Products